Table 1 Shows demographic details of patients, hemodynamic data and main CMR measurements
Positive DSMR (n = 15) | Negative DSMR (n = 10) | |
|---|---|---|
Age (years) | 66 ± 8 | 59 ± 12 |
Female | 3 | 4 |
Hypertension | 15 | 7 |
Diabetes mellitus | 3 | 5 |
Hyperlipedemia | 12 | 4 |
Known CAD | 1 | 0 |
Time between DSMR and coronary angiogramm (weeks) | 4 ± 12 | 8 ± 20 |
Hemodynamic data | ||
Peak heart rate (bpm) | 136 ± 12 | 143 ± 9 |
Heart rate at rest (bpm) | 66 ± 9 | 70 ± 9 |
Peak BP (mmHg) | 146/73 ± 28/13 | 131/68 ± 17/9 |
BP at rest (mmHg) | 141/76 ± 22/14 | 129/71 ± 15/13 |
Maximum dobutamine dose (μg/kg/min) | 36 ± 7 | 37 ± 5 |
Atropin dose (ml) | 0.6 ± 0.3 | 0.25 ± 0.04 |
MRI parameter | ||
LVEF (%) | 61 + 4 | 62 ± 4 |
LVEDV (ml) | 154 ± 31 | 143 ± 32 |
LVESV (ml) | 60 ± 14 | 54 ± 14 |